Skip to main content
logo
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
40.11
-1.66 (-3.97%)
Aug 28, 2026, 4:00 PM EDT - Market closed

IDEAYA Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
234.13218.71723.3950.9327.94
Revenue Growth
3244.67%3024.43%-70.07%-54.09%82.28%43.01%
Gross Profit
-85.24-95.99-287.67-106.12-38.61-30.22
Operating Income
-216.95-159.31-326.98-134.43-62.5-50.27
Net Income
-175.02-113.7-274.48-112.96-58.66-49.76
Earnings Per Share
-1.96-1.28-3.36-1.96-1.42-1.41
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,2431,0501,082632.61373.15368.06
Total Debt
29.3127.9119.172.873.485.18
Net Cash (Debt)
1,2141,0221,063629.73369.66362.88
Net Cash Growth
25.72%-3.88%68.80%70.35%1.87%31.07%
Net Cash Per Share
13.5611.5513.0110.958.9210.29

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-111.66-71.1-247.58-115.22-87.18-55.78
Capital Expenditures
-2.21-2.37-3.86-2.37-3.44-2.64
Free Cash Flow
-113.87-73.47-251.44-117.59-90.62-58.42
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-36.41%-43.89%---75.80%-108.15%
Operating Margin
-92.66%-72.84%-4671.07%-574.85%-122.72%-179.91%
Pretax Margin
-74.75%-51.99%-3921.10%-483.05%-115.17%-178.10%
Profit Margin
-74.75%-51.99%-3921.10%-483.05%-115.17%-178.10%
FCF Margin
-48.64%-33.59%-3592.01%-502.85%-177.92%-209.09%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-68.3668.3668.3668.3668.36
PS Ratio
16.5313.86317.3398.0717.1732.57